Australian breakthrough in stem cell kidney research

May 4, 2018, Murdoch Children's Research Institute
Australian breakthrough in stem cell kidney research
Credit: Murdoch Children's Research Institute

New research led by the Murdoch Children's Research Institute (MCRI), has combined gene editing technology with stem cell kidney regeneration to correct a patient's gene mutation.

This is the first time a patient has had kidney regenerated from their stem in Australia.

The research, is part of a regenerative medicine project in which human stem cells are used to develop mini-kidneys with a view to discovering new and treatments for inherited .

In this new study, published in the American Journal of Human Genetics and involving hospitals and laboratories in Brisbane, Sydney and Melbourne, stem cells derived from a child with genetic kidney were grown into two sets of living mini-kidney organoids – one with her kidney disease and one in which her was corrected.

The stem cells were created from a skin biopsy taken from 12-year-old Alexandria, who suffers from Mainzer-Saldino Syndrome, a rare genetic condition causing progressive retinal degeneration and end-stage kidney disease.

"Within the patient's mini-kidneys, we discovered abnormally shaped cellular antennae. This showed that Alexandria's disease exists within the mini-kidney and proves that we can use these regenerated tissues to learn about her disease," said MCRI researcher and paediatric nephrologist, Dr. Tom Forbes.

"We then used gene editing technology to correct the genetic mutation in Alexandria's stem cells. These 'gene-corrected' stem cells were then grown into another set of mini-kidneys which showed the antennae were now a normal shape. So the gene-correction stopped the development of the disease within the mini-kidney."

"By comparing the two mini-kidneys, we now have a better understanding of how this disease develops."

Alexandria's is the first reported case in which the effect of a gene mutation in kidney disease has been investigated using gene editing of patient stem cells to correct the genetic mutation.

"The fact that we can make from human stem cells and then correct any to study the way the disease develops is a very promising step towards developing personalised future treatment," said MCRI senior research officer Dr. Sara Howden.

At least 50% of children who require dialysis or a have a genetic cause for their kidney disease. For almost all of these conditions, very little is known about how the disease develops and no specific treatment exists.

"By growing mini-kidneys from a patient's stem cells we're hoping to find new genes responsible for kidney disease. We also hope we can test them for possible new treatments for that patient's specific disease."

While this latest research won't impact Alexandria's current condition, it does pave the way for possible treatments in future for other patients with similar renal diseases.

"There is a long way to go to make personalised treatments, but knowing we can study inherited kidney disease using a patient's is a breakthrough step," said Dr. Howden.

Alexandria's story:

When she was six months old, Alexandria was diagnosed with a degenerative vision impairment, however the cause was unknown. Five years later, with only three per cent kidney function, Alex suffered renal failure and was immediately placed on dialysis.

At six years of age, Alex underwent a renal transplant using a donated by her grandmother. While the transplant was a success and Alex's kidneys began to function well, the cause of her renal failure was also unknown.

Alex was 10 years old when genetic testing undertaken by Genetics Health Queensland finally led to an answer. Alex was diagnosed with a called Mainzer-Saldino Syndrome. This was very exciting news for Alex and her family as it has given them some resolution to her diagnosis and access to current research into the condition.

Now in year seven, Alex loves taekwondo, swimming, dancing, performing, reading and trying new things. She is a very determined young lady and an inspiration to everyone she meets.

Explore further: Researchers move one step closer towards functioning kidney tissue from stem cells

Related Stories

Researchers move one step closer towards functioning kidney tissue from stem cells

March 2, 2018
Researchers from the Murdoch Children's Research Institute (MCRI), University of Melbourne and Leiden University Medical Centre (LUMC) in The Netherlands have made an important step towards making human kidneys from stem ...

First drug approved for most common inherited kidney disease

April 24, 2018
The U.S. Food and Drug Administration has approved the first drug to slow kidney decline in patients with the most common inherited kidney disease.

Mini-kidneys grown in lab reveal renal disease secrets

October 2, 2017
By creating and manipulating mini-kidney organoids that contain a realistic micro-anatomy, UW Medicine researchers can now track the early stages of polycystic kidney disease. The organoids are grown from human stem cells.

Mini-kidney organoids re-create disease in lab dishes

October 23, 2015
Mini-kidney organoids have now been grown in a laboratory by using genome editing to re-create human kidney disease in petri dishes.

Massive single-cell survey of kidney cell types reveals new paths to disease

April 6, 2018
The kidney is a highly complex organ - far beyond a simple filter. Its function requires intricate interactions between many highly specialized cell types to extract waste, balances body fluids, form urine, regulate blood ...

New findings on tolvaptan as autosomal dominant polycystic kidney disease treatment

November 5, 2017
A phase 3 trial studying the effects of tolvaptan has found that the drug slowed the rate of decline in kidney function in patients with the most common form of polycystic kidney disease, a condition with no cure. The results ...

Recommended for you

Critical role of DHA on foetal brain development revealed

August 17, 2018
Duke-NUS researchers have found evidence that a natural form of Docosahexaenoic Acid (DHA) made by the liver called Lyso-Phosphatidyl-Choline (LPC-DHA), is critical for normal foetal and infant brain development, and that ...

New algorithm could improve diagnosis of rare diseases

August 17, 2018
Today, diagnosing rare genetic diseases requires a slow process of educated guesswork. Gill Bejerano, Ph.D., associate professor of developmental biology and of computer science at Stanford, is working to speed it up.

Gene silencing critical for normal breast development

August 17, 2018
Researchers have discovered that normal breast development relies on a genetic 'brake', a protein complex that keeps swathes of genes silenced.

Officials remove special rules for gene therapy experiments

August 16, 2018
U.S. health officials are eliminating special regulations for gene therapy experiments, saying that what was once exotic science is quickly becoming an established form of medical care with no extraordinary risks.

Genetic link discovered between circadian rhythms and mood disorders

August 15, 2018
Circadian rhythms are regular 24-hour variations in behaviour and activity that control many aspects of our lives, from hormone levels to sleeping and eating habits.

Ovarian cancer genetics unravelled

August 14, 2018
Patterns of genetic mutation in ovarian cancer are helping make sense of the disease, and could be used to personalise treatment in future.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.